Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Recruiting N/A Interventional Study
Cervical Cancer Gynecologic Cancer Recurrent Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
Tata Memorial Hospital · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a prospective study to evaluate in-field disease control, survival and late toxicity in patients with cervical cancer or pelvic recurrence treated with spatially fractionated RT. The study will include patients with primary cervical cancer or pelvic recurrence not suitable for brachytherapy in view of anticipated or actual suboptimal target coverage due to aberrant anatomy or large residu…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients with cervical cancer post EBRT, with expected suboptimal brachytherapy dose coverage due to- 1. Aberrant uterine or pelvic anatomy leading to difficulty in localization of the cervical OS or negotiation of the uterine canal accurately by two independent clinician…
Contacts

Supriya Chopra, MD

022-68735000

supriyasastri@gmail.com

CONTACT

Ankita Gupta, MD

9592750011

ankita19.gupta.ag@gmail.com

CONTACT